We identified a powerful synergism between γδ T cell and CD8+ T cells in the eradication of tumour cells, including CSC-like cells, suggesting that novel immunotherapies may benefit from a combination of MHC-restricted and non-MHC-restricted approaches. The gene discussed is HLA-C; the disease is neoplasm.